These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 16083348)

  • 1. Peroxisome proliferator-activated receptor beta/delta as a therapeutic target for metabolic diseases.
    Bedu E; Wahli W; Desvergne B
    Expert Opin Ther Targets; 2005 Aug; 9(4):861-73. PubMed ID: 16083348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders.
    Palomer X; Barroso E; Pizarro-Delgado J; Peña L; Botteri G; Zarei M; Aguilar D; Montori-Grau M; Vázquez-Carrera M
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29558390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.
    Coll T; Rodrïguez-Calvo R; Barroso E; Serrano L; Eyre E; Palomer X; Vázquez-Carrera M
    Curr Mol Pharmacol; 2009 Jan; 2(1):46-55. PubMed ID: 20021445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
    Wagner KD; Wagner N
    Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Δ
    Hirao-Suzuki M; Takeda S; Watanabe K; Takiguchi M; Aramaki H
    Arch Biochem Biophys; 2019 Feb; 662():219-225. PubMed ID: 30553767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
    Naruhn S; Toth PM; Adhikary T; Kaddatz K; Pape V; Dörr S; Klebe G; Müller-Brüsselbach S; Diederich WE; Müller R
    Mol Pharmacol; 2011 Nov; 80(5):828-38. PubMed ID: 21862691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver.
    Sanderson LM; Boekschoten MV; Desvergne B; Müller M; Kersten S
    Physiol Genomics; 2010 Mar; 41(1):42-52. PubMed ID: 20009009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) protects against ceramide-induced cellular toxicity in rat brain astrocytes and neurons by activation of ceramide kinase.
    Aleshin S; Reiser G
    Mol Cell Neurosci; 2014 Mar; 59():127-34. PubMed ID: 24513118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart.
    Burkart EM; Sambandam N; Han X; Gross RW; Courtois M; Gierasch CM; Shoghi K; Welch MJ; Kelly DP
    J Clin Invest; 2007 Dec; 117(12):3930-9. PubMed ID: 18037994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
    Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
    J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the role of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) in colon, breast, and lung carcinogenesis.
    Peters JM; Foreman JE; Gonzalez FJ
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):619-40. PubMed ID: 22037942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing the Role of PPARβ/δ in Carcinogenesis.
    Peters JM; Gonzalez FJ; Müller R
    Trends Endocrinol Metab; 2015 Nov; 26(11):595-607. PubMed ID: 26490384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of PPARβ/δ in the management of metabolic syndrome and its associated cardiovascular complications.
    Benetti E; Patel NS; Collino M
    Endocr Metab Immune Disord Drug Targets; 2011 Dec; 11(4):273-84. PubMed ID: 21696362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor beta/delta and retinoic acid receptor.
    Berry DC; Noy N
    Mol Cell Biol; 2009 Jun; 29(12):3286-96. PubMed ID: 19364826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARbeta/delta ligands as modulators of the inflammatory response.
    Kilgore KS; Billin AN
    Curr Opin Investig Drugs; 2008 May; 9(5):463-9. PubMed ID: 18465655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Blockade of PPAR Isoforms Increases Conditioned Fear Responding in the Presence of Nociceptive Tone.
    Gaspar JC; Okine BN; Llorente-Berzal A; Roche M; Finn DP
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32102354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.